All4Nutra
Late-stage functionalization is an economical approach to optimize the properties of drug candidates. However, the chemical complexity of drug molecules often makes late-stage diversification challenging. To address this problem, a late-stage functionalization platform based on geometric deep learning and high-throughput reaction screening was developed. Considering borylation as a critical step in late-stage functionalization, the computational model predicted reaction yields for diverse reaction conditions with a mean absolute error margin of 4–5%, while the reactivity of novel reactions with known and unknown substrates was classified with a balanced accuracy of 92% and 67%, respectively.
The regioselectivity of the major products was accurately captured with a classifier F-score of 67%. When applied to 23 diverse commercial drug molecules, the platform successfully identified numerous opportunities for structural diversification. The influence of steric and electronic information on model performance was quantified, and a comprehensive simple user-friendly reaction format was introduced that proved to be a key enabler for seamlessly integrating deep learning and high-throughput experimentation for late-stage functionalization.
Download the full article as PDF here Enabling late-stage drug diversification by high-throughput experimentation with geometric deep learning
or read it here
Nippa, D.F., Atz, K., Hohler, R. et al. Enabling late-stage drug diversification by high-throughput experimentation with geometric deep learning. Nat. Chem. (2023). https://doi.org/10.1038/s41557-023-01360-5
Read also more on Machine Learnings here:
- Optimizing environmental sustainability in pharmaceutical 3D printing through machine learning
- Revolutionizing Drug Formulation Development: The Increasing Impact of Machine Learning
- Paediatric Medicinal Formulation Development Utilising Human Taste Panels and Incorporating Their Data into Machine Learning Training
